TrialMind by Keiji AI
AI agents for clinical research
Analyze study data, review the literature, and plan clinical trials, with the sources, methods, and code your team can check.
Use cases
How teams use TrialMind, from biostatistics to health economics. Each use case has a short video and example outputs.

Biostatistics & Trial Design
Statistical programming and trial designLearn more ›

Real-World Evidence
Feasibility and cohort studies on real-world dataLearn more ›

Competitive & Portfolio Intelligence
Clinical trial landscapes, with sourcesLearn more ›

Clinical Development & Operations
Site selection, patient matching, and monitoringLearn more ›

Health Economics & Market Access
Literature reviews and health technology assessment dossiersLearn more ›

Research Institutions
Analyze your institution's data in plain languageLearn more ›
Customer examples1
Weeks → minutes
A precision oncology diagnostics company
Oncology feasibility studies, run by 20+ data scientists on their own database.
Months → days
A global biopharmaceutical company
Medical directors refining eligibility criteria by comparing them with registered trials.
No code
Two academic medical centers
Clinical researchers analyzing institutional data in plain language, reviewing each analysis plan before it runs.
Why TrialMind
Auditable outputs
Every answer carries its sources. Every analysis ships with the code and plan behind it.
Runs in your environment
Deployed inside your cloud, on the data you already license. Raw records do not leave your environment.
Built on published research
Ten years of AI research for drug development, published in Nature, Nature Biomedical Engineering, Nature Communications, and NeurIPS.
Customers and technology partners
From top pharma companies to universities and academic medical centers.
Technology partners
Bring a question from your work
We run it in TrialMind with you and walk through the results, sources, and code.
- 1. Deployed customers, described by organization type rather than name. Named references are available under a non-disclosure agreement (NDA).






